510(k) K781909
K781909 is an FDA 510(k) premarket notification submitted by Cambridge Nuclear Radiopharmaceutical for the device "CALCITONIN 125". The FDA issued a decision of Substantially Equivalent on January 10, 1979. The device falls under product code JKR (Radioimmunoassay, Calcitonin), a Class II device regulated under 21 CFR 862.1140.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 10, 1979
- Date Received
- November 14, 1978
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Calcitonin
- Device Class
- Class II
- Regulation Number
- 862.1140
- Review Panel
- CH
- Submission Type